Antibody data
- Antibody Data
- Antigen structure
- References [6]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 12134-2-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#12134-2-AP, RRID:AB_2212191
- Product name
- UBE2C antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated UBE2C antibody (Cat. #12134-2-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IHC, IP, WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Identifying the Key Genes in Mouse Liver Regeneration After Partial Hepatectomy by Bioinformatics Analysis and in vitro/vivo Experiments.
Affinity-based protein profiling to reveal targets of puerarin involved in its protective effect on cardiomyocytes.
DNA primase subunit 1 deteriorated progression of hepatocellular carcinoma by activating AKT/mTOR signaling and UBE2C-mediated P53 ubiquitination.
SINAT E3 Ubiquitin Ligases Mediate FREE1 and VPS23A Degradation to Modulate Abscisic Acid Signaling.
UBE2C functions as a potential oncogene by enhancing cell proliferation, migration, invasion, and drug resistance in hepatocellular carcinoma cells.
RIZ1 negatively regulates ubiquitin-conjugating enzyme E2C/UbcH10 via targeting c-Myc in meningioma.
Zhao J, Yu SZ, Cai Q, Ma D, Jiang L, Yang LP, Yu ZY
Frontiers in genetics 2021;12:670706
Frontiers in genetics 2021;12:670706
Affinity-based protein profiling to reveal targets of puerarin involved in its protective effect on cardiomyocytes.
Huang S, Wang FJ, Lin H, Liu T, Zhao CX, Chen LG
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2021 Feb;134:111160
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2021 Feb;134:111160
DNA primase subunit 1 deteriorated progression of hepatocellular carcinoma by activating AKT/mTOR signaling and UBE2C-mediated P53 ubiquitination.
Zhu M, Wu M, Bian S, Song Q, Xiao M, Huang H, You L, Zhang J, Zhang J, Cheng C, Ni W, Zheng W
Cell & bioscience 2021 Feb 23;11(1):42
Cell & bioscience 2021 Feb 23;11(1):42
SINAT E3 Ubiquitin Ligases Mediate FREE1 and VPS23A Degradation to Modulate Abscisic Acid Signaling.
Xia FN, Zeng B, Liu HS, Qi H, Xie LJ, Yu LJ, Chen QF, Li JF, Chen YQ, Jiang L, Xiao S
The Plant cell 2020 Oct;32(10):3290-3310
The Plant cell 2020 Oct;32(10):3290-3310
UBE2C functions as a potential oncogene by enhancing cell proliferation, migration, invasion, and drug resistance in hepatocellular carcinoma cells.
Xiong Y, Lu J, Fang Q, Lu Y, Xie C, Wu H, Yin Z
Bioscience reports 2019 Apr 30;39(4)
Bioscience reports 2019 Apr 30;39(4)
RIZ1 negatively regulates ubiquitin-conjugating enzyme E2C/UbcH10 via targeting c-Myc in meningioma.
Cai Z, Zou Y, Hu H, Lu C, Sun W, Jiang L, Hu G
American journal of translational research 2017;9(5):2645-2655
American journal of translational research 2017;9(5):2645-2655
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- HeLa cells were subjected to SDS PAGE followed by western blot with 12134-2-AP(UBE2C antibody) at dilution of 1:500
- Sample type
- cell line
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The UBE2C antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human UBE2C. This antibody recognizes human,mouse,rat antigen. The UBE2C antibody has been validated for the following applications: ELISA, WB, IHC analysis.